脓毒症患者细胞因子表达水平及其对预后的影响
该研究回顾性分析郑州大学第一附属医院ICU 2020年1月至2022年12月收治的227例脓毒症患者临床资料,按28天预后分为生存组168例(生存率74.0%)和死亡组59例(死亡率26.0%)。死亡组APACHEⅡ评分、降钙素原(PCT)及IL-6水平显著高于生存组,血小板计数和血小板压积显著低于生存组;其他细胞因子(IL-2、IL-4、IL-10、TNF-α、IFN-γ、IL-17)两组间差异无统计学意义。二元Logistic回归显示APACHEⅡ评分和IL-6是影响脓毒症患者预后的独立危险因素。ROC曲线显示APACHEⅡ评分和IL-6对预后有一定预测价值。
要点
- 死亡组APACHEⅡ评分19.37±0.99 vs 生存组14.88±0.61,P<0.001;PCT死亡组12.39±2.94 μg/L vs 生存组4.14±0.90 μg/L,P<0.001。
- 死亡组IL-6水平577.66±143.16 ng/L显著高于生存组99.74±33.84 ng/L,P<0.001;其余细胞因子两组间差异无统计学意义。
- 二元Logistic回归显示APACHEⅡ评分(OR 1.050,95%CI 1.008-1.093,P=0.019)和IL-6(OR 1.001,95%CI 1.000-1.002,P=0.026)是影响脓毒症预后的独立危险因素。
- APACHEⅡ评分预测预后的AUC为0.754(95%CI 0.681-0.827,P<0.001),最佳截断值16.50分时敏感度72.6%、特异度69.9%。
- IL-6预测预后的AUC为0.592(95%CI 0.511-0.673,P=0.035),最佳截断值27.87 ng/L时敏感度67.2%、特异度52.8%。
适用人群与场景
- 2020年1月至2022年12月郑州大学第一附属医院ICU收治的脓毒症患者227例,按28天预后分为生存组168例和死亡组59例。
诊断标准与关键阈值
- APACHEⅡ评分预测脓毒症预后的最佳截断值为16.50分,敏感度72.6%、特异度69.9%。
- IL-6预测脓毒症预后的最佳截断值为27.87 ng/L,敏感度67.2%、特异度52.8%。
研究设计与关键结果
- 回顾性分析227例脓毒症患者,生存组168例(生存率74.0%),死亡组59例(死亡率26.0%)。
- 死亡组与生存组年龄(55.97±2.13岁 vs 54.67±1.11岁)和性别(男性71.2% vs 57.1%)差异均无统计学意义(均P>0.05)。
- 死亡组APACHEⅡ评分(19.37±0.99 vs 14.88±0.61,P<0.001)和PCT(12.39±2.94 μg/L vs 4.14±0.90 μg/L,P<0.001)显著高于生存组;血小板计数(144.75±12.50×10⁹/L vs 215.99±11.26×10⁹/L,P=0.001)和血小板压积[(0.14±0.01)% vs(0.19±0.01)%,P=0.001]显著低于生存组。
- 死亡组IL-6水平显著高于生存组(577.66±143.16 ng/L vs 99.74±33.84 ng/L,P<0.001);IL-2(2.44±0.38 ng/L vs 2.63±0.27 ng/L,P=0.708)、IL-4(3.26±0.67 ng/L vs 3.18±0.34 ng/L,P=0.913)、IL-10(33.22±5.13 ng/L vs 39.43±2.85 ng/L,P=0.262)、TNF-α(59.33±19.21 ng/L vs 48.79±29.87 ng/L,P=0.839)、IFN-γ(6.69±5.18 ng/L vs 1.81±0.16 ng/L,P=0.100)、IL-17(2.05±0.29 ng/L vs 2.58±0.33 ng/L,P=0.369)两组间差异均无统计学意义。
- 二元Logistic回归显示APACHEⅡ评分(OR 1.050,95%CI 1.008-1.093,P=0.019)和IL-6(OR 1.001,95%CI 1.000-1.002,P=0.026)是影响脓毒症患者预后的独立危险因素。
- ROC曲线显示APACHEⅡ评分预测预后的AUC为0.754(95%CI 0.681-0.827,P<0.001),IL-6的AUC为0.592(95%CI 0.511-0.673,P=0.035)。
证据类型、等级与局限
- 回顾性队列研究,单中心(郑州大学第一附属医院ICU),样本量227例。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为APACHEⅡ评分和IL-6水平对脓毒症患者预后有一定预测价值,APACHEⅡ评分和IL-6水平越高,脓毒症患者死亡概率越大。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To observe the expression level of cytokines in patients with sepsis and its effect on prognosis.
METHODS: The clinical data of sepsis patients admitted to the intensive care unit (ICU) of the First Affiliated Hospital of Zhengzhou University from January 2020 to December 2022 were analyzed retrospectively, including gender, age, and acute physiology and chronic health evaluation II (APACHE II), blood routine, procalcitonin (PCT), C-reactive protein (CRP), and cytokines levels [interleukins (IL-2, IL-4, IL-6, IL-10, IL-17), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ)] within 24 hours of admission to ICU. The 28-day prognosis of the patients was followed up. The patients were divided into survival group and death group according to the prognosis. The clinical data between the two groups of sepsis patients with different prognosis were compared. Binary Logistic regression analysis was used to analyze the independent risk factors affecting the prognosis of patients with sepsis, and the receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of each risk factor for the prognosis of patients with sepsis.
RESULTS: (1) A total of 227 patients with sepsis were enrolled, including 168 patients in the survival group (survival rate 74.0%) and 59 patients in the death group (mortality 26.0%). There were no significant differences in age (years old: 55.97±2.13 vs. 54.67±1.11) and gender (male: 71.2% vs. 57.1%) between the death group and the survival group (both P > 0.05), indicating that the baseline data of the two groups were comparable. (2) The APACHE II (19.37±0.99 vs. 14.88±0.61, P < 0.001) and PCT (μg/L: 12.39±2.94 vs. 4.14±0.90, P < 0.001) in the death group were significantly higher than those in the survival group, while the platelet count [PLT (×109/L): 144.75±12.50 vs. 215.99±11.26, P = 0.001] and thrombocytocrit [(0.14±0.01)% vs. (0.19±0.01)%, P = 0.001] were significantly lower than those in the survival group. (3) The level of IL-6 in the death group was significantly higher than that in the survival group (ng/L: 577.66±143.16 vs. 99.74±33.84, P < 0.001). There were no statistically significant differences in other cytokines, IL-2, IL-4, IL-10, TNF-α, IFN-γ and IL-17 between the death group and the survival group [IL-2 (ng/L): 2.44±0.38 vs. 2.63±0.27, P = 0.708; IL-4 (ng/L): 3.26±0.67 vs. 3.18±0.34, P = 0.913; IL-10 (ng/L): 33.22±5.13 vs. 39.43±2.85, P = 0.262; TNF-α (ng/L): 59.33±19.21 vs. 48.79±29.87, P = 0.839; IFN-γ (ng/L): 6.69±5.18 vs. 1.81±0.16, P = 0.100; IL-17 (ng/L): 2.05±0.29 vs. 2.58±0.33, P = 0.369]. (4) Binary Logistic regression analysis showed that APACHE II and IL-6 were independent risk factors affecting the prognosis of patients with sepsis [odds ratio (OR) and 95% confidence interval (95%CI) were 1.050 (1.008-1.093) and 1.001 (1.000-1.002), P values were 0.019 and 0.026, respectively]. (5) ROC curve analysis showed that APACHE II and IL-6 had certain predictive value for the prognosis of patients with sepsis, the area under the ROC curve (AUC) was 0.754 (95%CI was 0.681-0.827) and 0.592 (95%CI was 0.511-0.673), P values were < 0.001 and 0.035, respectively. When the optimal cut-off value of APACHE II was 16.50 score, the sensitivity was 72.6% and the specificity was 69.9%. When the optimal cut-off value of IL-6 was 27.87 ng/L, the sensitivity was 67.2% and the specificity was 52.8%.
CONCLUSIONS: APACHE II score and IL-6 level have certain predictive value for the prognosis of patients with sepsis, the higher APACHE II score and IL-6 level, the greater the probability of death in patients with sepsis.
参考来源
- Li P, Yang H, Cui Q, et al. [Expression level of cytokines in patients with sepsis and its effect on prognosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 38149385. doi:10.3760/cma.j.cn121430-20230818-00660
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。